Lyell Immunopharma (LYEL) News
NASDAQ: LYELHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.80+0.22 (+1.62%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LYEL news summary
We found 4 recent headlines mentioning Lyell Immunopharma (LYEL): 0 in the past week and 4 in the past 30 days, most often from GlobeNewswire. For price context, LYEL is up 1.62% at $13.80. The most recent story, "Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2026", was published by GlobeNewswire on Nov 4, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Lyell Immunopharma headlines
- Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2026SOUTH SAN FRANCISCO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor…GlobeNewswire
- Lyell Immunopharma Announces $80 Million Private Placement to Advance Ronde-Cel Toward Planned BLA SubmissionSOUTH SAN FRANCISCO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor…GlobeNewswire
- Lyell Immunopharma to Present Positive Updated Ronde-Cel Data in More than 80 Patients at ASH 2026 from PiNACLE Pivotal Trial in 3L+ and from Phase 1/2 2L Cohort in Patients with Relapsed/Refractory Large B-Cell LymphomaSOUTH SAN FRANCISCO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing next-generation chimeric antigen receptor (CAR) T-cell…GlobeNewswire
- Lyell Immunopharma To Participate in November Investor EventsSOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor…GlobeNewswire